Takara Bio
An international team of researchers put nine immune cell sequencing methods head to head, including RNA-based and DNA-based ones, using the same T-cell sample.
The firm's SmartChip platform consists of a high-throughput liquid dispenser and a PCR instrument and can provide more than 5,000 reactions in one run.
Takara Bio, BioSyntagma Develop High-Throughput SARS-CoV-2 Detection Method
The new method uses Takara Bio's SmartChip PCR instrument, chips, and reagents to run 5,184 reactions per chip in less than 30 minutes.
Both studies emerged from the ongoing Human Cell Atlas project and could help scientists decide on the best approaches to use in various contexts.
Namocell, Takara Bio, HepaTx Partner on Single-Cell Genomics for Late-Stage Liver Disease
The partners will use Namocell's single-cell dispensing tool and Takara's Smart-seq technology to isolate and characterize HepaTx's hepatocyte-like cells.Â
Feb 15, 2017
WaferGen Expects 62 Percent Rise in Q4 Revenues
Dec 15, 2016
Takara Bio USA to Acquire Rubicon Genomics
Nov 28, 2016
WaferGen Enacts Reverse Stock Split
Nov 16, 2016
Wafergen Stockholders Approve Takara Bio Merger
May 13, 2016
Takara Bio to Acquire WaferGen Biosystems
May 10, 2016
WaferGen Biosystems Q1 Revenues Up 68 Percent
Apr 26, 2016
Takara Bio, IDT Form RNA Sequencing Partnership
Nov 10, 2015
WaferGen Q3 Revenues Jump 54 Percent
Oct 22, 2015